Home|Journals|Articles by Year|Audio Abstracts

Review Article

Open Vet J. 2020; 10(4): 412-430

What are potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?

Carina Sacoor,Luís Meireles Barros,Liliana Montezinho.

Cited by 9 Articles

Chronic inflammatory enteropathies in dogs are characterized by persistent or recurrent gastrointestinal signs that last for more than three weeks. Despite unclarity in the etiopathogenesis, it is considered that a genetic predisposition associated with environmental factors, such as dietary antigens and the intestinal microbiota, might induce an abnormal immune response in the host. The diagnosis of this condition requires full investigation in order to exclude all other possible causes.
Currently, observation of clinical signs associated with histopathologic evaluation and systematic therapeutic trials is the gold standard for the diagnosis of chronic enteropathies.
Furthermore, diagnosis, monitoring the disease progression and treatment response evaluation can be exhausting, since this whole process is time-consuming, costly and partially invasive.
Therefore, biomarkers appear as non-invasive tools, which can be useful in evaluating gastrointestinal function, identifying the presence of disease and assessing its natural progression, monitoring gastrointestinal inflammation, predicting response to treatment and clinical outcomes.
Over the past decade, several studies were conducted in order to explore the clinical utility of biomarkers. Thus, the aim of this dissertation is to provide an overview of the biomarkers considered relevant in the diagnosis and management of dogs with chronic inflammatory enteropathies. The biomarkers addressed in this study may be serological, present in urine and feces or even tissue- derived.
This study argues that biomarkers, in particular calprotectin and calgranulin c, have great potential to be used in clinical practice in the diagnosis and management of dogs affected dogs. However, a single biomarker cannot assuredly predict disease severity, progression, response to treatment and clinical outcome. Therefore, in order to achieve greater accuracy, it would be beneficial if these tools are used in conjunction with the contemporary ones. Future research is needed with the aim of better determine the usefulness of these tools in chronic inflammatory enteropathies in dogs.

Key words: Biomarkers; Chronic enteropathies; Inflammatory bowel disease; Dog.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.